What conditions does Pulse Biosciences, Inc. run trials for?

In our tracked recruiting trials, Pulse Biosciences, Inc. sponsors trials for Atrial Fibrillation, Atrial Fibrillation Paroxysmal, Cardiac Ablation.

Clinical trials sponsored by Pulse Biosciences, Inc.

Recruiting trials

Conditions studied

Not applicable 4

Condition	Trials
Atrial Fibrillation	4
Atrial Fibrillation Paroxysmal	2
Cardiac Ablation	2
Cardiac Arrhythmia	2
AF	1
Ablation	1
Ablation of Atrial Fibrillation	1
Clamp Study	1
Maze Procedure	1
Surgery	1

CellFX® Nanosecond Pulsed Field Ablation (PFA) 360 Catheter Ablation System for Treatment of Atrial Fibrillation
NCT06696170 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 3 locations
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
NCT06959121 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · 3 locations
CellFX® nsPFA™ Cardiac Surgery System to Treat Atrial Fibrillation
NCT06355063 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · 6 locations
NS-PFA Catheter Ablation of Paroxysmal Atrial Fibrillation With the Pulse Biosciences CellFX System
NCT07018596 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location